Profile for European Patent Office Patent: 3043784
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for European Patent Office Patent: 3043784
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 9,908,845 | Sep 5, 2034 | Merck Sharp Dohme | WELIREG | belzutifan |
| RE49948 | Sep 5, 2034 | Merck Sharp Dohme | WELIREG | belzutifan |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
